A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine
Kana Yamamoto, Takahisa Mashiba, Keisuke Takano, Toshihiko Suzuki, Masahiro Kami, Morihito Takita, Eiji Kusumi, Yasuhiro Mizuno, Tamae Hamaki
Abstract
COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationExacerbationSubclinical infectionAtrial fibrillationPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakFood and drug administrationAdministration (probate law)VirologyPediatricsInternal medicineMedical emergencyPolitical scienceDiseaseOutbreakInfectious disease (medical specialty)LawSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesThyroid Disorders and Treatments